• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Various Rating Actions Taken On European Synthetic CDO Tranches—March 2008 Mar 08

  • ID: 2031280
  • March 2008
  • Region: Europe
  • Standard & Poors

FEATURED COMPANIES

  • Argon Capital PLC
  • Claris III Ltd.
  • Coriolanus Ltd.
  • Deutsche Bank AG
  • Eirles Two Ltd.
  • Elva Funding PLC
  • MORE

Abstract
LONDON (Standard & Poor's) March 27, 2008Standard & Poor's Ratings Services said today that it has taken credit rating actions on 81 European synthetic collateralized debt obligation (CDO) tranches (see list below). Specifically, the ratings on: 58 tranches were removed from CreditWatch with negative implications and lowered; 21 tranches were lowered and remain on CreditWatch negative; and Two tranches were removed from CreditWatch positive and raised. Of the 79 tranches lowered: 20 reference U.S. residential mortgage-backed mortgages (RMBS) and U.S. CDOs that are exposed to U.S. RMBS, which have experienced recent negative rating actions; and 59 have experienced corporate downgrades in their portfolios. The 81 tranches represent 3.1% of the total number of European synthetic...

Companies mentioned in this report are:
- Argon Capital PLC
- Deutsche Bank AG
- Eirles Two Ltd.
- Coriolanus Ltd.
- Xelo PLC
- Elva Funding PLC
- Omega Capital Investments PLC
- Starling Finance PLC
- Khamsin Credit Products (Netherlands) II B.V.
- Claris III Ltd.
- Asset Repackaging Trust Six B.V.

Action: Downgraded
Action: On CreditWatch:Negative
Action: READ MORE >

Note: Product cover images may vary from those shown

- Argon Capital PLC
- Deutsche Bank AG
- Eirles Two Ltd.
- Coriolanus Ltd.
- Xelo PLC
- Elva Funding PLC
- Omega Capital Investments PLC
- Starling Finance PLC
- Khamsin Credit Products (Netherlands) II B.V.
- Claris III Ltd.
- Asset Repackaging Trust Six B.V.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.